Clinical Trials Browser

Phase 2 × Skin Neoplasms × Eflornithine × Clear all

NCT00204789 2019-12-16

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

Phase 2 Completed

Skin Neoplasms